Show simple item record

dc.contributor.authorHope, DL
dc.contributor.authorDickfos, ST
dc.contributor.authorEllerby, RE
dc.contributor.authorKing, MA
dc.date.accessioned2018-12-12T01:30:43Z
dc.date.available2018-12-12T01:30:43Z
dc.date.issued2016
dc.identifier.issn1445-937X
dc.identifier.doi10.1002/jppr.1179
dc.identifier.urihttp://hdl.handle.net/10072/100872
dc.description.abstractBackground: Medicare and the Pharmaceutical Benefits Scheme may suggest to patients that medicines supply is the same everywhere in Australia. National Registration of Health Practitioners removed barriers to practitioners working interstate. Aim: To identify variations in state and territory medicines legislation with potential to negatively impact patients or practitioners. Method: Australian state and territory Acts and Regulations related to medicines prescribing and provision were compared. Legislative variations with potential to either harm patients, or increase health practitioners’ legal or ethical risk, were identified. Results: Potential patient harm may occur due to inconsistent requirements for prescription particulars, retention of prescription repeats by pharmacies in some states, or variation in age restriction on medicines provision. Potential practitioner risk may arise due to inconsistencies in practitioners’ prescribing rights or variable requirements to prescribe or dispense medicines. Conclusion: Ideally, all Australian states and territories should adopt uniform medicines legislation.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherWiley Online
dc.relation.ispartofpagefrom201
dc.relation.ispartofpageto208
dc.relation.ispartofissue3
dc.relation.ispartofjournalJournal of Pharmacy Practice and Research
dc.relation.ispartofvolume46
dc.subject.fieldofresearchClinical Pharmacy and Pharmacy Practice
dc.subject.fieldofresearchClinical Pharmacy and Pharmacy Practice
dc.subject.fieldofresearchPharmacology and Pharmaceutical Sciences
dc.subject.fieldofresearchcode111503
dc.subject.fieldofresearchcode111503
dc.subject.fieldofresearchcode1115
dc.titleBorderline health: jurisdictional variation in Australian medicines legislation poses potential risks to patients and healthcare practitioners
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
dc.description.versionPost-print
gro.facultyGriffith Health, School of Pharmacy and Pharmacology
gro.rights.copyright© 2016 The Society of Hospital Pharmacists of Australia. This is the peer reviewed version of the following article: Borderline health: jurisdictional variation in Australian medicines legislation poses potential risks to patients and healthcare practitioners, Journal of Pharmacy Practice and Research, Volume 46, Issue 3, Pages 201-208, 2016, which has been published in final form at https://doi.org/10.1002/jppr.1179. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
gro.hasfulltextFull Text
gro.griffith.authorKing, Michelle A.
gro.griffith.authorHope, Denise


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record